Clinical and Cost Benefits to Create Greater Demand for Orthopedic Biomaterials.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c46312) has announced the addition of "European Orthopaedic Biomaterials Markets" to their offering. This Frost & Sullivan research service titled European Orthopedic Biomaterials Markets provides an overview of key market challenges and drivers. It also includes market forecasts and provides strategic recommendations for vendors. This research offers a description of the existing competitive structure and analyses important trends that affect market performance. In this research, Frost & Sullivans expert analysts thoroughly examine the following markets/applications/technologies: bone substitutes, degradable de·grad·a·ble adj. That can be chemically degraded: degradable plastic wastes. de·grad fixation and orthobiologics. Benefits of this Service * Market metrics metrics Managed care A popular term for standards by which the quality of a product, service, or outcome of a particular form of Pt management is evaluated. See TQM. * Decision support databases * Strategic Recommendations * Existing competitive structure Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research: By Application: * Bone Substitutes * Degradable Fixation * Orthobiologics The following technologies are covered in this research: * Biomaterials: Biomaterials are inorganic or organic natural or synthetic materials placed in the body, and are used to interface with biological systems to treat, amplify or replace any tissue, organ, or function of the body * Orthopedic biomaterials: Orthopaedic biomaterials can be implanted into or near a bone fracture to facilitate healing or to compensate a lack or loss of bone tissue. The materials used in orthopaedic surgery include ceramics, polymers, metals such as stainless steel stainless steel: see steel. stainless steel Any of a family of alloy steels usually containing 10–30% chromium. The presence of chromium, together with low carbon content, gives remarkable resistance to corrosion and heat. , cobalt-chromium and titanium and the shape memory alloy  This article or section needs copy editing for grammar, style, cohesion, tone and/or spelling.You can assist by [ editing it] now. NiTi, as well as re-absorbable materials such as bioglass, various modifications of hydroxyapatite hydroxyapatite /hy·droxy·ap·a·tite/ (-ap´ah-tit) an inorganic calcium-containing constituent of bone matrix and teeth, imparting rigidity to these structures. and bone grafts bone graft Orthopedic surgery Sterilized bony tissue, often of cadaveric origin, used to fill and/or 'sculpt' bone defects Indications Spinal fusion, revision of failed articular prostheses, filling traumatic or malignant bone defects, or periodontal defects. . The significant rise in musculoskeletal musculoskeletal /mus·cu·lo·skel·e·tal/ (-skel´e-t'l) pertaining to or comprising the skeleton and muscles. mus·cu·lo·skel·e·tal adj. Relating to or involving the muscles and the skeleton. diseases as a result of the increasing ageing population, combined with the growing incidence of osteoporosis and osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. are contributing to the enhanced use of orthopedic biomaterials in Europe. Accordingly, orthopedic biomaterials are finding use in craniomaxillofacial as well as orthopedic applications including synthetic bone grafts, degradable fixation and bone fillers. Clinical and cost advantages, the increase in biocompatibility biocompatibility the quality of not having toxic or injurious effects on biological systems. biocompatibility 1. The extent to which a foreign, usually implanted, material elicits an immune or other response in a recipient 2. as well as the benefit of improved recovery time are expected to support continued market growth. Hence, revenues in the orthopedic biomaterials market are anticipated to grow from $240.0 million in 2005 to $609.0 million by 2012. Rising expectations of improved-quality medical care and the rise in the number of medical breakthroughs are resulting in spiralling healthcare costs. As a result, governments are pursuing cost-reduction strategies to ensure sufficient allocation of funds towards healthcare services. However, the strategies implemented by governments are affecting the level of reimbursements for orthopedic biomaterials, says the analyst of this research service. In keeping with continued healthcare reforms and the present reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. budgets, market participants The term market participant is used in United States constitutional law to describe a U.S. State which is acting as a producer or supplier of a marketable good or service. When a state is acting in such a role, it may permissibly discriminate against non-residents. need to minimise costs. As the market is becoming increasingly competitive, price, service and product performance will become crucial factors for success. It is envisaged that in the near future, the competitive nature of the market will stimulate the development of innovative products and services as well as investments in capital and human resources The fancy word for "people." The human resources department within an organization, years ago known as the "personnel department," manages the administrative aspects of the employees. . Hence, it will become essential for smaller companies to invest in the development of leading technologies to improve their market share, says the analyst. In the context of clinical applications, manufacturers will also need to closely monitor end users' needs to address their expectations and improve their market presence. At present, manufacturers are expressing concern over the scope, validity and enforceability of patents for product innovations and other proprietary rights held by third parties. Hence, ensuring the enforcement of patents and intellectual property laws will become vital. Clearly, market success will depend on a company's ability to obtain the intellectual property and regulatory approval prior to other competitors, which will assist in optimising sales to gain a crucial competitive edge in the market. For more information visit http://www.researchandmarkets.com/reports/c46312. Source: Frost & Sullivan |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion